CRIS
CURIS INCCompany Information
- Company Name
- CURIS INC
- CIK
- CIK0001108205
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CRIS: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- CRIS
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-03-31
- Last sale
- —
- Shares purchased (TTM)
- 10,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 22,408,237
- Shares outstanding
- 2,135,906
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- -25.00%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 5 | 15 | 5 | 9 | 10 | 20 | 20 | 21 | 10 | 30 | 27 | 24 | ||||||
| Marketable Securities Current | - | - | - | - | - | - | 0 | 0 | 18 | 11 | 30 | 44 | ||||||
| Accounts Receivable Net Current | - | - | 0 | 3 | 3 | 2 | 3 | 3 | 3 | 2 | 3 | 3 | ||||||
| Restricted Cash Current | 1 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 4 | 3 | 2 | 2 | ||||||
| Assets Current | 7 | 17 | 7 | 14 | 14 | 25 | 26 | 27 | 35 | 46 | 61 | 73 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Restricted Cash Noncurrent | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | ||||||
| Other Assets Noncurrent | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | ||||||
| Goodwill | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | ||||||
| Assets | 19 | 30 | 20 | 28 | 29 | 39 | 41 | 42 | 50 | 62 | 77 | 90 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 5 | 7 | 6 | 4 | 4 | 5 | 3 | 4 | 2 | 4 | 3 | 5 | ||||||
| Accrued Liabilities Current | 7 | 7 | 7 | 7 | 7 | 6 | 7 | 8 | 7 | 6 | 9 | 7 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Long Term Debt Current | - | - | 0 | 7 | 7 | 7 | 8 | - | - | - | 9 | - | ||||||
| Liabilities Current | 14 | 15 | 14 | 20 | 19 | 20 | 19 | 22 | 19 | 11 | 22 | 14 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 2 | ||||||
| Liabilities | 14 | 17 | 15 | 42 | 43 | 46 | 47 | 51 | 51 | 53 | 58 | 60 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 1,285 | 1,284 | 1,253 | 1,252 | 1,245 | 1,244 | 1,234 | 1,221 | 1,219 | 1,217 | 1,216 | 1,214 | ||||||
| Retained Earnings Accumulated Deficit | -1,280 | -1,272 | -1,247 | -1,267 | -1,259 | -1,250 | -1,240 | -1,230 | -1,220 | -1,208 | -1,196 | -1,185 | ||||||
| Stockholders Equity | 5 | 13 | 5 | -15 | -14 | -7 | -6 | -9 | -1 | 9 | 20 | 30 | ||||||
| Liabilities And Stockholders Equity | 19 | 30 | 20 | 28 | 29 | 39 | 41 | 42 | 50 | 62 | 77 | 90 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 568 | 68 | 68 | 68 | 68 | 34 | 34 | 34 | 34 | 23 | 23 | 23 | ||||||
| Common Stock Shares Issued | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Shares Outstanding | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCURIS INC (CRIS) — SEC Financial Statements & Analysis
CURIS INC (CRIS) is a biological products, (no diagnostic substances) company, incorporated in DE. CURIS INC trades on Nasdaq as: CRIS. CURIS INC (CRIS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, CURIS INC carries a market cap of $22.21M, a P/E ratio of -1.05x, a P/B ratio of 4.73x, a P/S ratio of 5.15x, an enterprise value of $16.60M, and an EV/EBITDA multiple of -1.91x. On profitability, it posts an operating margin of -203.15%, a net margin of -490.33%, a Return on Equity (ROE) of 455.34%, a Return on Assets (ROA) of -87.76%, and a Return on Invested Capital (ROIC) of -350.08%. Per share, it reports EPS of $-9.90, diluted EPS of $-9.90, free cash flow per share of $-14.32, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -62.17% year-over-year, net income growth of -45.65% year-over-year, and EPS growth of -83.93% year-over-year. On the balance sheet, it maintains a current ratio of 0.49x, a quick ratio of 0.41x, working capital of $-6.95M, a debt-to-equity ratio of 3.04x, a debt ratio of 0.75, free cash flow of $-30.59M (TTM), and net debt of $-5.62M. Figures sourced from SEC EDGAR.
- Market Cap
- $22.21M
- P/E TTM
- -1.05x
- EPS TTM
- $-9.90
- P/B TTM
- 4.73x
- ROE TTM
- 455.34%
- ROA TTM
- -87.76%
- Debt To Equity
- 3.04x
- Free Cash Flow TTM
- $-30.59M
- Net Revenue TTM Growth 1Y
- -62.17%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CURIS INC in?
CURIS INC (CRIS) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does CRIS trade on?
CURIS INC (CRIS) trades on the Nasdaq.
Where is CURIS INC incorporated?
CURIS INC is incorporated in DE.
When was CURIS INC (CRIS)'s most recent SEC filing?
CURIS INC (CRIS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is CRIS's market cap?
CURIS INC (CRIS) has a market capitalization of $22.21M as of 2026-06-30.
What is CRIS's EPS (earnings per share)?
CURIS INC (CRIS)'s trailing twelve month EPS is $-9.90 as of 2026-06-30.
What is CRIS's ROE (return on equity)?
CURIS INC (CRIS)'s trailing twelve month Return on Equity (ROE) is 455.34% as of 2026-06-30.
What is CRIS's ROA (return on assets)?
CURIS INC (CRIS)'s trailing twelve month Return on Assets (ROA) is -87.76% as of 2026-06-30.
What is CRIS's ROIC (return on invested capital)?
CURIS INC (CRIS)'s trailing twelve month Return on Invested Capital (ROIC) is -350.08% as of 2023-12-31.
What is CRIS's EV/EBITDA?
CURIS INC (CRIS)'s trailing twelve month EV/EBITDA is -1.91x as of 2026-06-30.